Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Conference News ESC 2024

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Michael O'Riordan

September 09, 2024

News Conference News EuroPCR 2024

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

Michael O'Riordan

May 28, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2023

Shelley Wood

November 01, 2023

Presentation TCT 2023

A Prospective, Multicenter, Randomized Trial Comparing Sirolimus-Coated Balloon with Paclitaxel-Coated Balloon in De-Novo Small Vessels: The TRANSFORM I Trial

Presenter: Patrick Serruys

October 24, 2023

Presentation TCT 2023

Treatment of Coronary De-Novo Lesions by a Sirolimus or a Paclitaxel Coated Balloon in a European Population

Presenter: Bruno Scheller

October 24, 2023

News Daily News

Top Endovascular News of 2022

L.A. McKeown

January 03, 2023

News Conference News

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

L.A. McKeown

November 18, 2022

JSousa1.cropped (002) in memoriam_header

News Daily News

Stent Pioneer José Eduardo Sousa Dies, Age 88

Shelley Wood

March 14, 2022

Presentation TCT 2021

A Novel Sirolimus-Eluting Iron-Based Bioresorbable Scaffold Implantation in Single De Novo Coronary Lesions: Two-Year Clinical and Imaging Outcomes from the First in Man Study (IBS-FIM)

Presenter: Runlin Gao

November 05, 2021

News Conference News TCT 2021

OPTIMIZE: 2-Year DES Data Affirm Need for Meaningful MI Definitions

L.A. McKeown

October 25, 2021

News Daily News

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

L.A. McKeown

October 05, 2021

News Conference News ESC 2021

OAC Analysis From MASTER DAPT Raises No Red Flags for Shorter DAPT

Shelley Wood

September 02, 2021

News Conference News ESC 2021

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

Shelley Wood

August 28, 2021

News

Drug-Coated Balloons for CAD: Some International Consensus

L.A. McKeown

May 27, 2020

News Conference News ACC 2020

PCI Equal to Surgery in Left Main CAD: PRECOMBAT at 10 Years

Michael O'Riordan

March 30, 2020

News Conference News LINC 2020

COMPARE: Similar Efficacy and Safety for Paclitaxel Balloons Regardless of Dose

L.A. McKeown

January 28, 2020

News Conference News EuroPCR 2019

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Michael O'Riordan

May 27, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for February 2019

Shelley Wood

March 01, 2019

Advertisement

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

What’s Going to Be Big at TCT 2024?

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

TCTMD’s Top 10 Most Popular Stories for October 2023

A Prospective, Multicenter, Randomized Trial Comparing Sirolimus-Coated Balloon with Paclitaxel-Coated Balloon in De-Novo Small Vessels: The TRANSFORM I Trial

Treatment of Coronary De-Novo Lesions by a Sirolimus or a Paclitaxel Coated Balloon in a European Population

Top Endovascular News of 2022

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

Stent Pioneer José Eduardo Sousa Dies, Age 88

A Novel Sirolimus-Eluting Iron-Based Bioresorbable Scaffold Implantation in Single De Novo Coronary Lesions: Two-Year Clinical and Imaging Outcomes from the First in Man Study (IBS-FIM)

OPTIMIZE: 2-Year DES Data Affirm Need for Meaningful MI Definitions

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

OAC Analysis From MASTER DAPT Raises No Red Flags for Shorter DAPT

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

Drug-Coated Balloons for CAD: Some International Consensus

PCI Equal to Surgery in Left Main CAD: PRECOMBAT at 10 Years

COMPARE: Similar Efficacy and Safety for Paclitaxel Balloons Regardless of Dose

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

TCTMD’s Top 10 Most Popular Stories for February 2019

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content